BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anondita Medicare IPO is Open!
Apply for the Anondita Medicare IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524711

VISTAPH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VISTA PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, VISTA PHARMACEUTICALS LTD. share price is currently at ₹ 10.3, which is down by ₹ -0.35 from its previous closing. Today, the stock has fluctuated between ₹ 10.26 and ₹ 10.84. Over the past year, VISTA PHARMACEUTICALS LTD. has achieved a return of -26.32 %. In the last month alone, the return has been -7.29 %. Read More...

Investment Returns

Over 1 Month -7.29% Over 3 Months -7.63% Over 6 Months -7.46% Over 1 Year -26.32%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VISTA PHARMACEUTICALS LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    64.00

  • P/E Ratio (TTM)

    -12.84

  • Beta

    0.48

  • Book Value / share

    10.59

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -1.29

info icon alternate text

VISTA PHARMACEUTICALS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 1.52
Operating Expense 3.00
Net Profit -1.29
Net Profit Margin (%) -84.86
Earnings Per Share (EPS) -0.22
EBITDA -1.11
Effective Tax Rate (%) 12.83
Particulars MAR 2025 (Values in Cr)
Revenue 3.23
Operating Expense 4.54
Net Profit -1.50
Net Profit Margin (%) -46.43
Earnings Per Share (EPS) -0.79
EBITDA -0.67
Effective Tax Rate (%) -40.56
Particulars DEC 2024 (Values in Cr)
Revenue 2.56
Operating Expense 4.47
Net Profit -1.32
Net Profit Margin (%) -51.56
Earnings Per Share (EPS) -0.07
EBITDA -1.39
Effective Tax Rate (%) 26.66
Particulars SEP 2024 (Values in Cr)
Revenue 2.49
Operating Expense 3.75
Net Profit -0.97
Net Profit Margin (%) -38.95
Earnings Per Share (EPS) -0.16
EBITDA -0.82
Effective Tax Rate (%) 22.40
Particulars JUN 2024 (Values in Cr)
Revenue 1.80
Operating Expense 3.03
Net Profit -0.86
Net Profit Margin (%) -47.77
Earnings Per Share (EPS) -0.15
EBITDA -0.71
Effective Tax Rate (%) 26.49
Particulars MAR 2025 (Values in Cr)
Revenue 10.07
Operating Expense 15.80
Net Profit -4.65
Net Profit Margin (%) -46.17
Earnings Per Share (EPS) -0.79
EBITDA -3.59
Effective Tax Rate (%) 12.09
Particulars MAR 2024 (Values in Cr)
Revenue 10.29
Operating Expense 15.80
Net Profit -4.51
Net Profit Margin (%) -43.82
Earnings Per Share (EPS) -1.03
EBITDA -3.24
Effective Tax Rate (%) 12.93
Particulars MAR 2023 (Values in Cr)
Revenue 1.00
Operating Expense 7.28
Net Profit -5.66
Net Profit Margin (%) -566.00
Earnings Per Share (EPS) -1.54
EBITDA -4.05
Effective Tax Rate (%) 3.57
Particulars MAR 2022 (Values in Cr)
Revenue 0.39
Operating Expense 3.12
Net Profit -0.83
Net Profit Margin (%) -212.82
Earnings Per Share (EPS) -0.24
EBITDA -1.04
Effective Tax Rate (%) 67.57
Particulars MAR 2021 (Values in Cr)
Revenue 1.27
Operating Expense 5.27
Net Profit -2.01
Net Profit Margin (%) -158.26
Earnings Per Share (EPS) -0.54
EBITDA -1.52
Effective Tax Rate (%) 47.24
Particulars MAR 2024 (Values in Cr)
Book Value / Share 7.56
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.23
EBITDA Margin -31.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.31
EBITDA Margin -392.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.64
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.34
EBITDA Margin -282.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.42
EBITDA Margin -120.47
Particulars MAR 2020 (Values in Cr)
Book Value / Share 9.76
ROE % -11.25
ROCE % -5.21
Total Debt to Total Equity 0.41
EBITDA Margin -4.61
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 57.97
Total Liabilities 57.97
Total Equity 40.46
Share Outstanding 47164899
Price to Book Ratio 1.41
Return on Assets (%) -7.78
Return on Capital (%) -9.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 56.02
Total Liabilities 56.02
Total Equity 36.70
Share Outstanding 37556639
Price to Book Ratio 1.03
Return on Assets (%) -10.10
Return on Capital (%) -12.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 55.58
Total Liabilities 55.58
Total Equity 35.45
Share Outstanding 36793907
Price to Book Ratio 0.96
Return on Assets (%) -1.59
Return on Capital (%) -1.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 50.85
Total Liabilities 50.85
Total Equity 32.84
Share Outstanding 36793907
Price to Book Ratio 1.01
Return on Assets (%) -3.94
Return on Capital (%) -4.61
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 51.12
Total Liabilities 51.12
Total Equity 29.64
Share Outstanding 30365337
Price to Book Ratio 0.54
Return on Assets (%) -7.19
Return on Capital (%) -8.15
Particulars MAR 2024 (Values in Cr)
Net Income -5.17
Cash from Operations -4.91
Cash from Investing -0.78
Cash from Financing 5.59
Net change in Cash -0.10
Free Cash Flow -4.12
Particulars MAR 2023 (Values in Cr)
Net Income -5.87
Cash from Operations -2.76
Cash from Investing -1.27
Cash from Financing 3.11
Net change in Cash 0.13
Free Cash Flow -1.49
Particulars MAR 2022 (Values in Cr)
Net Income -2.61
Cash from Operations -0.99
Cash from Investing -0.01
Cash from Financing 0.93
Net change in Cash -0.06
Free Cash Flow -0.97
Particulars MAR 2021 (Values in Cr)
Net Income -3.68
Cash from Operations -6.74
Cash from Investing -0.29
Cash from Financing 6.96
Net change in Cash -0.08
Free Cash Flow -6.44
Particulars MAR 2020 (Values in Cr)
Net Income -3.93
Cash from Operations 0.80
Cash from Investing -1.72
Cash from Financing 0.28
Net change in Cash -0.64
Free Cash Flow 1.04
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 34.22 13.97 1.87 262.24 30.00 / 69.75
BLISS GVS PHARMA LTD 166.55 16.47 1.67 1757.06 105.05 / 190.65
CIPLA LTD 1545.85 23.16 4.00 124866.66 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 342.40 9.64 2.77 1007.72 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2785.40 49.83 24.18 47186.36 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 34.22 18.60 5.40 262.24 30.00 / 69.75
AMRUTAJAN HEALTH LTD 722.05 38.28 6.39 2087.49 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8450.65 99.90 27.42 21126.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 166.55 24.90 1.65 1757.06 105.05 / 190.65

VISTA PHARMACEUTICALS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
10.40 -2.43 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 10.50
  • 26 Days 10.70
  • 10 Days 10.60
  • 50 Days 10.80
  • 12 Days 10.60
  • 100 Days 10.90
  • 20 Days 10.70
  • 200 Days 11.30
10.27 PIVOT

First Support

9.92

First Resistance

10.52

Second Support

9.67

Second Resistance

10.87

Third Support

9.32

Third Resistance

11.12

RSI

40.69

ADX

49.16

MACD

-0.11

Williams % R

-90.85

Commodity Channel Index (CCI)

-292.23

Date

2025-08-20

Week

3703.00

Same Day

4313.00

Month

4348.00

1 Year

0.48

3 Year

0.39

Over 1 Month

-7.29%

down

Over 1 Year

-26.32%

down

Over 3 Months

-7.63%

down

Over 3 Years

13.27%

down

Over 6 Months

-7.46%

down

Over 5 Years

2.22%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

VISTA PHARMACEUTICALS LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

VISTA PHARMACEUTICALS LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
25 Jun 2015 10.0 2.0 26 Jun 2015

VISTA PHARMACEUTICALS LTD. Share Price

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. The Company is engaged in the formulation of pharmaceutical products. It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India.

The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum. Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

The Company was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market of expanding Globally. It is the first Indian Company to obtain USFDA Approvals to produce OTC as well as Prescription Drugs to US Market in 1994. It is the first Indian Company to export OTC as well as Prescription Drugs to US in 1996.

The Company's Indian Facility got USFDA Approval in June 2010 to produce ANDA products to US Market. It established an extensive Marketing and Distribution Network in the United States. The Company operations are going on as per USFDA cGMP norms. The validations and stability testing studies are going on as per schedules. Its state-of-the-art Facility in India is built according to cGMP and US-FDA standards.

Parent organization Indian Private
NSE symbol [-]
Founded 1991
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vista Pharmaceuticals Ltd?

Answer Field

Vista Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 10.40 as on Aug 22 2025 03:26 PM.

What is the Market Cap of Vista Pharmaceuticals Ltd Share?

Answer Field

The market cap of Vista Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 64.00 as on Aug 22 2025 03:26 PM.

What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Vista Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 14.85 and ₹ 9.10.

What is 1 year return for Vista Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Vista Pharmaceuticals Ltd Share?

Answer Field

As on Aug 22 2025 03:26 PM the price-to-earnings (PE) ratio for Vista Pharmaceuticals Ltd share is -12.84.

What is the PB ratio of Vista Pharmaceuticals Ltd Share?

Answer Field

As on Aug 22 2025 03:26 PM, the price-to-book (PB) ratio for Vista Pharmaceuticals Ltd share is 10.59.

How to Buy Vista Pharmaceuticals Ltd Share?

Answer Field

You can trade in Vista Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vista Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Vista Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vista Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91